ArticleBMC cancer2025

Efficacy of second-line treatment for gemcitabine-refractory unresectable pancreatic cancer in a real-world setting.

Qianqian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.